ELAVL1 and neoplasm: Furthermore, a comprehensive analysis of HuR in the context of tumor immunotherapy had unveiled a pronounced immune rejection response in patients with low HuR levels, whereas those with high HuR expression exhibited an intensified state of immune evasion.